Projected Earnings Date: 2024-07-19    (Delayed quote data   2025-01-03)
Last
 0.60
Change
 ⇓ -0.02   (0.00%)
Volume
  189,129
Open
 0.61
High
 0.68
Low
 0.56
8EMA (Daily)
 0.60
40EMA (Daily)
 0.63
50EMA (Daily)
 0.63
STO (Daily)
 53.091
MACD Hist (Daily)
 0.000
8EMA (Weekly)
 0.625
40EMA (Weekly)
 0.76
50EMA (Weekly)
 0.83
STO (Weekly)
 44.571
MACD Hist (Weekly)
 0.027
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com